HPVC2019-159: Biopharmaceuticals Long-Acting Granulocyte-Colony Stimulating Factor
Current Contract
Contract start date: 28 Jun 2019
Contract end date: 29 Jan 2026
Option periods: Nil
Description
Contract for the provision of long acting granulocyte colony-stimulating factor (G-CSF) to Victorian public hospitals and health services.Additional information
Contract Details
The Principal Period (2 years) commenced on 28 June 2019 until 27 June 2021.
The first Contract Option period of two years has been executed - effective from 28 June 2021 until 27 June 2023.
The second Contract Option period of two years has been executed – effective from 28 June 2023 until 27 June 2025.
Contract has been extended - effective 28 June 2025 until 29 January 2026.
Option Periods Remaining
Nil.
Categories
Category 1: Biopharmaceuticals Long-Acting Granulocyte Colony-Stimulating Factor